Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
Multi-State Bust: Cyber Police Nab Seven For Duping Mumbai Businessman Of Nearly ₹11 Crore In Fake Share Scheme
Punjab News: 3 Of Cross-Border Arms Smuggling Module Held With 7 Pistols
Mantralaya Directs Departments To Ensure Correct Spelling Of Street Names On Documents After High Court Order
Maharashtra Clamps Down On Spending, Halts Last-Minute Purchases In Bid To Manage Fiscal Strain
